Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin.
Publication
, Conference
Erba, HP; Stadtmauer, EA; Larson, RA; Sievers, EL; Estey, EH; Lowenberg, B; Leopold, LH; Berger, MS; Herbertson, R; Appelbaum, FR
Published in: BLOOD
November 16, 2002
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2002
Volume
100
Issue
11
Start / End Page
339A / 339A
Location
PHILADELPHIA, PENNSYLVANIA
Publisher
AMER SOC HEMATOLOGY
Conference Name
44th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Erba, H. P., Stadtmauer, E. A., Larson, R. A., Sievers, E. L., Estey, E. H., Lowenberg, B., … Appelbaum, F. R. (2002). Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin. In BLOOD (Vol. 100, pp. 339A-339A). PHILADELPHIA, PENNSYLVANIA: AMER SOC HEMATOLOGY.
Erba, H. P., E. A. Stadtmauer, R. A. Larson, E. L. Sievers, E. H. Estey, B. Lowenberg, L. H. Leopold, M. S. Berger, R. Herbertson, and F. R. Appelbaum. “Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin.” In BLOOD, 100:339A-339A. AMER SOC HEMATOLOGY, 2002.
Erba HP, Stadtmauer EA, Larson RA, Sievers EL, Estey EH, Lowenberg B, et al. Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin. In: BLOOD. AMER SOC HEMATOLOGY; 2002. p. 339A-339A.
Erba, H. P., et al. “Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin.” BLOOD, vol. 100, no. 11, AMER SOC HEMATOLOGY, 2002, pp. 339A-339A.
Erba HP, Stadtmauer EA, Larson RA, Sievers EL, Estey EH, Lowenberg B, Leopold LH, Berger MS, Herbertson R, Appelbaum FR. Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin. BLOOD. AMER SOC HEMATOLOGY; 2002. p. 339A-339A.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2002
Volume
100
Issue
11
Start / End Page
339A / 339A
Location
PHILADELPHIA, PENNSYLVANIA
Publisher
AMER SOC HEMATOLOGY
Conference Name
44th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology